Observational Study Evaluating Effectiveness and Safety of Real-World Treatment with Damoctocog alfa pegol in Previously Treated Patients with Hemophilia A (HEM-POWR) First published 29/05/2019 Last updated 08/04/2024 EU PAS number:EUPAS26416 Study Ongoing